MedPath

Activity, Balance and COPD (ABCOPD)

Recruiting
Conditions
COPD
Interventions
Other: No intervention being delivered.
Registration Number
NCT04006015
Lead Sponsor
Imperial College London
Brief Summary

This research project incorporates a series of studies to investigate the relationship between physical performance (e.g. tests of strength, balance and walking distance) and physical activity (activity measured in day to day life) in people with COPD and other chronic lung diseases.

Detailed Description

The research project incorporates the following components:

Study 1) A prospective, observational study, to assess the relationship between a comprehensive set of measures of walking ability, strength and balance, and daily physical activity in people with chronic lung disease. Patients will attend a single assessment session to evaluate physical capacity. They will also wear a physical activity monitor for a week following completing these tests to assess physical activity and aspects of physical performance. Participants will also be invited to return two months later to provide evidence about the repeatability of measurements.

Study 2) A parallel study comparing assessment of performance during six-minute walk tests by an observer to a semi-automated assessment using an activity monitor worn by the patient. This will involve a single visit and be carried out during walking tests carried out as part of routine clinical care.

Study 3) A qualitative study to investigate experiences and perceptions of participants of dance groups for people with chronic lung disease, as a novel form of physical activity. This will be used to inform the design of subsequent trials of dance interventions for chronic lung disease.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Adults with stable chronic lung disease
  • Able to understand instructions.
  • Age and sex matched healthy controls.
Read More
Exclusion Criteria
  • For the main study, the presence of other comorbidities causing a significant reduction in mobility (for example stroke with neurological deficits, severe arthritis, significant peripheral neuropathy, significant visual impairment, dementia etc.).
  • exacerbation of lung disease within the last 2 months.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Qualitative dance substudyNo intervention being delivered.We will aim for 20 participants.
Main study groupNo intervention being delivered.31 people with COPD and 31 controls in the main study group.
six-minute walk substudyNo intervention being delivered.We will aim to have 40 participants participating in the 6 minute walk sub-study.
Primary Outcome Measures
NameTimeMethod
Free-living gait stability as assessed by activity monitor7 days.

The free-living gait stability parameters derived from the fixed body sensor worn during activity monitoring at home.

Secondary Outcome Measures
NameTimeMethod
Timed Up and Go (TUG)Assessed during a single clinical assessment at baseline.

Time in seconds to complete the standard TUG protocol

Physical performance assessmentAssessed during single clinical assessment at baseline.

Assessed using the Short Physical Performance Battery (SPPB) in clinical setting.

Balance confidenceAssessed during a single clinical assessment at baseline.

Assessed using the Activities-specific Balance Confidence (ABC) scale. This is a self completed measure of balance confidence during common activities of daily living. It includes 16 questions which participant give a percentage confidence response with 0% being not confident at all and 100% being completely confident. There is also a total score out from 0% (least confident) to 100% (most confident) for overall balance confidence, which average created by combining the scores given for the separate questions.

Clinical balance assessmentAssessed during single clinical assessement at baseline.

Assessed using the miniBESTest in clinical setting.

Physical activity assessed by step count using activity monitor7 days.

Physical activity assessed using step count (number of steps), as assessed using the activity monitor at home (McRoberts MoveMonitor).

Walking distance in metresAssessed during a single clinical assessment at baseline.

Assessed using the six-minute walk test in clinical setting.

Patient experience as assessed by semi-structured interviews1 hour.

The patients experience assessed by semi-structured interviews in focus group.

Physical Activity: Movement intensity (in average body acceleration (g) during activity)7 days.

Movement intensity measurement is assessed using the fixed body sensor worn during activity monitoring at home.

Physical activity: types of activity (time in minutes spent standing, walking, lying, sitting, cycling, running) assessed with activity monitor.7 days.

Types of activity (time measured in minutes spent standing, walking, lying, sitting, cycling, running) is assessed using the fixed body sensor worn during activity monitoring at home.

Functional reach testAssessed during a single clinical assessment at baseline.

Assessed using standard functional reach protocol

Trial Locations

Locations (1)

National Heart and Lung Institute, Imperial College London

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath